OpenURL Connection Search

Select item for more details and to access through your institution.

A randomized placebo-controlled trial of the efficacy of denosumab in Indian postmenopausal women with osteoporosis.
Published in:
Indian Journal of Endocrinology & Metabolism, 2015, v. 19, n. 1, p. 148, doi. 10.4103/2230-8210.146871
By:
- Pitale, Shailesh;
- Thomas, Mathew;
- Rathi, Gaurav;
- Deshmukh, Vaishali;
- Kumar, Prasanna;
- Reddy, Sanjay;
- Shetty, Naresh;
- Kakar, Atul;
- Babhulkar, Sushrut;
- Mody, Bharat;
- Chacko, Jacob;
- Acharya, Sudeep;
- Joglekar, Sadhna;
- Halbe, Vipul;
- Kravitz, Barbara G.;
- Waterhouse, Brian;
- Fitzpatrick, Antonio J. Nino Lorraine A.
Publication type:
Article
Rosiglitazone decreases bone mineral density and increases bone turnover in postmenopausal women with type 2 diabetes mellitus.
Published in:
2013
By:
- Bilezikian, John P;
- Josse, Robert G;
- Eastell, Richard;
- Lewiecki, E Michael;
- Miller, Colin G;
- Wooddell, Margaret;
- Northcutt, Allison R;
- Kravitz, Barbara G;
- Paul, Gitanjali;
- Cobitz, Alexander R;
- Nino, Antonio J;
- Fitzpatrick, Lorraine A
Publication type:
Journal Article
Effect of Rosiglitazone, Metformin, and Glyburide on Bone Biomarkers in Patients with Type 2 Diabetes.
Published in:
Journal of Clinical Endocrinology & Metabolism, 2010, v. 95, n. 1, p. 134, doi. 10.1210/jc.2009-0572
By:
- Zinman, Bernard;
- Haffner, Steven M.;
- Herman, William H.;
- Holman, Rury R.;
- Lachin, John M.;
- Kravitz, Barbara G.;
- Paul, Gitanjali;
- Jones, Nigel P.;
- Aftring, R. Paul;
- Viberti, Giancarlo;
- Kahn, Steven E.
Publication type:
Article
Rosiglitazone Decreases C-Reactive Protein (CRP) Relative to Glyburide and Metformin over Four-Years in Spite of Greater Weight Gain.
Published in:
Diabetes, 2007, v. 56, p. A176
By:
- Haffner, Steven M.;
- Kahn, Steven E.;
- Zinman, Bernard;
- Holman, Rury R.;
- Viberti, Giancarlo F.;
- Herman, William H.;
- Lachin, John M.;
- Kravitz, Barbara G.;
- Heise, Mark A.
Publication type:
Article
The Effectiveness of Metformin versus Glyburide in Type 2 Diabetes: Results from ADOPT (A Diabetes Outcomes Progression Trial).
Published in:
Diabetes, 2007, v. 56, p. A146
By:
- Herman, William H.;
- Haffner, Steven M.;
- Kahn, Steven E.;
- Zinman, Bernard;
- Holman, Rury R.;
- Viberti, Giancarlo F.;
- Lachin, John M.;
- Kravitz, Barbara G.;
- Heise, Mark A.
Publication type:
Article
Determinants of Monotherapy Failure in ADOPT (A Diabetes Outcomes Progression Trial).
Published in:
Diabetes, 2007, v. 56, p. A66
By:
- Holman, Rury R.;
- Kahn, Steven E.;
- Haffner, Steven M.;
- Zinman, Bernard;
- Viberti, Giancarlo F.;
- Herman, William H.;
- Lachin, John M.;
- Kravitz, Barbara G.;
- Heise, Mark A.
Publication type:
Article
Obesity Is a Major Determinant of the Association of C-Reactive Protein Levels and the Metabolic Syndrome in Type 2 Diabetes.
Published in:
Diabetes, 2006, v. 55, n. 8, p. 2357, doi. 10.2337/db06-0116
By:
- Kahn, Steven E.;
- Zinman, Bernard;
- Haffner, Steven M.;
- O'Neill, M. Colleen;
- Kravitz, Barbara G.;
- Yu, Dahong;
- Freed, Martin I.;
- Herman, William H.;
- Holman, Rury R.;
- Jones, Nigel P.;
- Lachin, John M.;
- Viberti, Giancarlo C.
Publication type:
Article
Rosiglitazone decreases C-reactive protein to a greater extent relative to glyburide and metformin over 4 years despite greater weight gain: observations from a Diabetes Outcome Progression Trial (ADOPT).
Published in:
2010
By:
- Kahn SE;
- Haffner SM;
- Viberti G;
- Herman WH;
- Lachin JM;
- Kravitz BG;
- Yu D;
- Paul G;
- Holman RR;
- Zinman B;
- Diabetes Outcome Progression Trial (ADOPT) Study Group;
- Kahn, Steven E;
- Haffner, Steven M;
- Viberti, Giancarlo;
- Herman, William H;
- Lachin, John M;
- Kravitz, Barbara G;
- Yu, Dahong;
- Paul, Gitanjali;
- Holman, Rury R
Publication type:
journal article
Rosiglitazone Decreases C-Reactive Protein to a Greater Extent Relative to Glyburide and Metformin Over 4 Years Despite Greater Weight Gain.
Published in:
Diabetes Care, 2010, v. 33, n. 1, p. 177, doi. 10.2337/dc09-1661
By:
- Kahn, Steven E.;
- Haffner, Steven M.;
- Viberti, Giancarlo;
- Herman, William H.;
- Lachin, John M.;
- Kravitz, Barbara G.;
- Yu, Dahong;
- Paul, Gitanjali;
- Holman, Rury R.;
- Zinman, Bernard
Publication type:
Article
Rosiglitazone-Associated Fractures in Type 2 Diabetes.
Published in:
Diabetes Care, 2008, v. 31, n. 5, p. 845, doi. 10.2337/dc07-2270
By:
- Kahn, Steven E.;
- Zinman, Bernard;
- Lachin, John M.;
- Haffner, Steven M.;
- Herman, William H.;
- Holman, Rury R.;
- Kravitz, Barbara G.;
- Yu, Dahong;
- Heise, Mark A.;
- Aftring, R. Paul;
- Viberti, Giancarlo
Publication type:
Article
Effects of Rosiglitazone, Glyburide, and Metformin on β-Cell Function and Insulin Sensitivity in ADOPT.
Published in:
Diabetes, 2011, v. 60, n. 5, p. 1552, doi. 10.2337/db10-1392
By:
- Kahn, Steven E.;
- Lachin, John M.;
- Zinman, Bernard;
- Haffner, Steven M.;
- Aftring, R. Paul;
- Paul, Gitanjali;
- Kravitz, Barbara G.;
- Herman, William H.;
- Viberti, Giancarlo;
- Holman, Rury R.
Publication type:
Article

Found: 11